Company intelligence
Onalabs Inno-Hub
The future of biomonitoring.
About Onalabs Inno-Hub
Point-of-Care (POC) technologies, designed to provide rapid clinical diagnosis at, or near the site of patient care, has the potential to sense changes in well-known biomarkers used already to monitor patients with chronic cardiac and respiratory diseases. However, they need to be measured in blood, which limit their use only in medical institutions. Our non-invasive products based on wearable formats will empower the patients and their families to measure relevant biomarkers anytime and anywhere, allowing them to detect and monitor early stages of possible clinical deterioration, which could prelude in earlier (self-)management strategies, resulting in shorter hospital stays and prevention of unnecessary treatments. Our social impact will be a priority. Our challenge is addressed to patients of all ages, from neonates with congenital heart disease and bronchiolitis’, to the elderly with chronic heart failure due to myocardial infarction or chronic lung diseases and asthma. Our product offers continuous, non-invasive monitoring that have a positive health impact to the health deterioration. We will support active aging and improve the self-management of health.
Verified activity
Signals from Onalabs Inno-Hub
2 published signals
Presence & Recognition
Onalabs Inno-Hub is presenting its ONASPORT technology at the Sea Otter Europe event in Girona from 18 to 20 September 2026 at the Y13-B stand.
Reported by Onalabs Inno-Hub
Presence & Recognition
Onalabs Inno-Hub CEO and cofounder Elisabet Del Valle participated in a round table discussion on deep tech investment and the role of strategic technologies at the 40th anniversary of the AMETIC conference in Santander.
Reported by Onalabs Inno-Hub